Helen Torley - Feb 15, 2022 Form 4 Insider Report for HALOZYME THERAPEUTICS, INC. (HALO)

Role
President and CEO, Director
Signature
/s/ James R. Oehler as attorney-in-fact for Helen Torley
Stock symbol
HALO
Transactions as of
Feb 15, 2022
Transactions value $
-$237,292
Form type
4
Date filed
2/17/2022, 05:02 PM
Previous filing
Feb 14, 2022
Next filing
Nov 17, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HALO Common Stock Options Exercise $0 +13.1K +2.25% $0.00 594K Feb 15, 2022 Direct
transaction HALO Common Stock Tax liability -$237K -6.89K -1.16% $34.43 587K Feb 15, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HALO Restricted Stock Units Options Exercise $0 -13.1K -25% $0.00 39.3K Feb 15, 2022 Common Stock 13.1K $0.00 Direct F2
transaction HALO Option to Purchase Common Stock Award $0 +257K $0.00 257K Feb 16, 2022 Common Stock 257K $34.36 Direct F3
transaction HALO Restricted Stock Units Award $0 +84K $0.00 84K Feb 16, 2022 Common Stock 84K $0.00 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported disposition of 6,892 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations.
F2 This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer.
F3 This option vests one-fourth on such date and then 1/48th monthly thereafter.
F4 This award vests one-fourth on the first anniversary of the grant date and then one-fourth on each anniversary date thereafter.